2 Huge Dividend Stocks That Investors Should Consider Buying This Summer

Featured in:
abcd

Image Source: Getty Images

A great way to grow wealth is to buy and hold good dividend stocks, in my opinion. It’s worth remembering, however, that dividends are never guaranteed.

sadasda

The two types I think investors should consider are: Keller Group (LSE:KLR) and Impact on REIT Health (LSE: YOU).

Let me explain!

Building the future

Specialist soil engineering firm Keller Group essentially helps prepare the ground for the construction of buildings. If you’re not familiar with construction, this is a key undertaking in any construction project.

Keller Group shares have had an excellent 12 months and are up 69% in the period, from 783p at the same time last year to the current level of 1,330p.

From a bullish perspective, Keller is making a lot of money in the US. This could be key to his future earnings and potential ongoing rewards as the US government looks to spend billions on infrastructure in the coming years. The recently passed US infrastructure bill could assist with this, and Keller could capitalize on it.

The stock currently offers a dividend yield of 3.5%. While this is not the highest available on the market, I am interested in more regular payouts and vivid prospects for the future.

The final bullish point I will note is that the stock looks like good value for money despite the recent share price rally. It is currently trading at a price-to-earnings ratio of just 10. However, if the stock continues to rally, that valuation may soon be unattainable.

On the bearish side, there are risks. The most vital one for me is that any economic shocks could halt infrastructure spending, especially across the pond in the US. This could have a significant impact on earnings, as well as any returns I would like to receive. Another concern is the ongoing battle with inflation, which threatens to squeeze margins in the construction industry related to operating and raw material costs.

Impact on REIT Health

Founded as a real estate investment trust (REIT), Impact makes money from healthcare-related rental properties. These companies are required to return 90% of their profits to shareholders, making them attractive investments to buy for their dividends.

Please note that tax treatment depends on each client’s individual circumstances and may change in the future. The content of this article is provided for informational purposes only. It is not intended to, and does not, constitute tax advice of any kind.

In contrast to Keller, Impact shares have fallen 4% over the 12-month period, from 90p during the same period last year to 86p today.

I believe this is due to economic turbulence, such as higher interest rates and inflation, causing problems in the commercial real estate sector. The biggest risk is continued problems across the macro picture. Higher rates mean that growth, profits and returns are harder to achieve. Growth is harder because of the more steep debt that REITs apply to fund growth aspirations.

On the other hand, I like Impact for a few reasons. First, it has defensive qualities, as healthcare is a basic need, regardless of the economic outlook. Furthermore, as the UK population grows and ages, the demand for healthcare will only escalate, which could give Impact the opportunity to escalate its returns and rewards for investors.

In addition, the fundamentals also look good. The stock looks good value for money with a price-to-earnings ratio of just eight. Finally, the huge dividend yield of 8.8% is very attractive!

abcd
sadasda

Find us on

Latest articles

Related articles

See more articles

Israel Stocks Rise at Close of Trade; TA 35...

Investing.com – The Israeli stock market close ended trading higher on Sunday, as gains in the and...

The US agency warns that a prolonged government shutdown...

by David Shepardson WASHINGTON (Reuters) - The head of the Transportation Security Administration warned on Thursday...

Lilly’s Zepbound weight loss therapy becomes the first FDA-approved...

Author: Bhanvi Satiya (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's...

Here are the 10 highest growth stocks on the...

Image source: Getty Images The FTSEespecially...